ES2073688T3 - Rotogranulaciones y revestimiento de enmascaramiento del sabor para la preparacion de tabletas farmaceuticas masticables. - Google Patents

Rotogranulaciones y revestimiento de enmascaramiento del sabor para la preparacion de tabletas farmaceuticas masticables.

Info

Publication number
ES2073688T3
ES2073688T3 ES91307913T ES91307913T ES2073688T3 ES 2073688 T3 ES2073688 T3 ES 2073688T3 ES 91307913 T ES91307913 T ES 91307913T ES 91307913 T ES91307913 T ES 91307913T ES 2073688 T3 ES2073688 T3 ES 2073688T3
Authority
ES
Spain
Prior art keywords
rotogranulations
preparation
pharmaceutical tablets
masking coating
flavor masking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91307913T
Other languages
English (en)
Inventor
Edward J Roche
Susan M Papile
Eleanor M Freeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of ES2073688T3 publication Critical patent/ES2073688T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LAS TABLETAS DE MEDICAMENTOS MASTICABLES SE HACEN DE ROTOGRANULADOS REVESTIDOS DE UN MEDICAMENTO EN EL QUE SE FORMAN LOS ROTOGRANULOS DE UNA MEZCLA DE GRANULACION DEL MEDICAMENTO V. GR. LIGADOR FAMOTIDINA, V. GR. POLIVINILPIRROLIDONA, Y PORTADOR, V. GR. LACTOSA Y LOS ROTOGRANULADOS SE REVISTEN CON ACETATO DE CELULOSA, BUTIRATO ACETATO DE CELULOSA O UNA COMBINACION DE LOS MISMOS Y POLIVINIL PIRROLIDONA Y UN PROCESO PARA ELABORAR DICHAS TABLETAS Y UN METODO DE ENMASCARAR EL GUSTO DE LOS MEDICAMENTOS UTILIZANDO TALES ROTOGRANULOS REVESTIDOS.
ES91307913T 1990-08-30 1991-08-29 Rotogranulaciones y revestimiento de enmascaramiento del sabor para la preparacion de tabletas farmaceuticas masticables. Expired - Lifetime ES2073688T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57546590A 1990-08-30 1990-08-30

Publications (1)

Publication Number Publication Date
ES2073688T3 true ES2073688T3 (es) 1995-08-16

Family

ID=24300440

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91307913T Expired - Lifetime ES2073688T3 (es) 1990-08-30 1991-08-29 Rotogranulaciones y revestimiento de enmascaramiento del sabor para la preparacion de tabletas farmaceuticas masticables.

Country Status (8)

Country Link
EP (1) EP0473431B1 (es)
JP (1) JP3221891B2 (es)
KR (1) KR100214792B1 (es)
AU (1) AU633757B2 (es)
CA (1) CA2052679C (es)
DE (1) DE69108143T2 (es)
ES (1) ES2073688T3 (es)
MX (1) MX9100856A (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2079934C (en) * 1991-10-15 2002-09-03 Edward J. Roche Taste mask coatings for preparing chewable pharmaceutical tablets
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
US5523095A (en) * 1993-12-15 1996-06-04 Eastman Chemical Company Controlled release matrix system using cellulose acetate/polyvinylpyrrolidone blends
US5536505A (en) * 1993-12-15 1996-07-16 Eastman Chemical Company Controlled release matrix system using cellulose acetate/poly-2-ethyl-2-oxazoline blends
US5529783A (en) * 1994-12-19 1996-06-25 Mcneil-Ppc, Inc. Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
EP1679066A4 (en) * 2003-10-27 2011-06-22 Astellas Pharma Inc MEDICINAL COATING MICROPARTICLES FOR A MOUTH-DISABLE TABLET
RU2359670C2 (ru) 2004-03-25 2009-06-27 Астеллас Фарма Инк. Композиция солифенацина или его соли для использования в твердом препарате
US7815939B2 (en) 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
WO2007010930A1 (ja) * 2005-07-20 2007-01-25 Astellas Pharma Inc. 口腔内崩壊製剤用の薬物含有被覆微粒子及びその製造方法
CN109432291A (zh) * 2018-11-28 2019-03-08 哈尔滨新海德智能环境工程有限公司 一种中医慢性病缓释调理咀嚼颗粒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE861284L (en) * 1986-05-14 1987-11-14 Birex Res And Dev Ltd And Carm Controlled release ketoprofen.
NZ226822A (en) * 1987-11-16 1990-03-27 Mcneil Consumer Prod Chewable medicament tablet containing means for taste masking
GB8805695D0 (en) * 1988-03-10 1988-04-07 Nycomed As Enteric coated spheroidal granules
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.

Also Published As

Publication number Publication date
CA2052679A1 (en) 1992-03-01
DE69108143D1 (de) 1995-04-20
KR920003966A (ko) 1992-03-27
EP0473431B1 (en) 1995-03-15
DE69108143T2 (de) 1995-07-20
JP3221891B2 (ja) 2001-10-22
MX9100856A (es) 1992-04-01
KR100214792B1 (ko) 1999-08-02
EP0473431A1 (en) 1992-03-04
AU8349791A (en) 1992-03-05
AU633757B2 (en) 1993-02-04
CA2052679C (en) 1997-12-02
JPH06219939A (ja) 1994-08-09

Similar Documents

Publication Publication Date Title
ES2089403T3 (es) Recubrimiento para ocultar el sabor para la preparacion de tabletas farmaceuticas masticables.
ES2073677T3 (es) Revestimientos de liberacion sostenida y enmascaramiento del sabor para productos farmaceuticos.
ES2073688T3 (es) Rotogranulaciones y revestimiento de enmascaramiento del sabor para la preparacion de tabletas farmaceuticas masticables.
ES2081349T3 (es) Rotogranulaciones y recubrimientos para enmascarar el sabor para la preparacion de comprimidos farmaceuticos de mascar.
ES2052060T3 (es) Enmascaramiento del sabor del timol.
NO178564C (no) Framgangsmåte for framstilling av et system for administrering av aktive medikamenter gjennom slimhinner
MX169815B (es) Tableta de medicamento masticable que contiene medios para enmascarar el sabor
ES2088550T3 (es) Recubrimientos que ocultan el sabor para preparar comprimidos farmaceuticos masticables.
FI905684A0 (fi) Farmaceutisk doseringsform foer utdelning av medicin aot fiskar.
NL187379C (nl) Therapeutisch systeem in de vorm van een verband voor de toediening van een geneesmiddel.
BE855713Q (fr) Nouveaux derives de 4-aminoquinoleine, leur procede de preparation et medicament les contenant
BE802996R (fr) Nouveaux derives de la 4-amino-quinazolines, leur preparation et medicaments contenant ces derives
NL184258B (nl) Werkwijze ter bereiding van een farmaceutisch aanvaardbare vorm van het geneesmiddel natrium 7-(d-alfa-formyloxy-alfa-fenylaceetamido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cefem-4-carboxylaat, alsmede werkwijze ter bereiding van een farmaceutisch preparaat.
FR2351995A1 (fr) Composes 9-(2-o-acyl-b-d-arabinofuranosyl)-adeniniques, leur procede de preparation et leur application en tant que medicaments
AR003434A1 (es) Compuesto de tiludronato, composiciones farmaceuticas que los contienen y proceso para producir dicho compuesto y procedimiento para producir lascomposiciones farmaceuticas.
AR028467A1 (es) MODIFICACION CRISTALINA B DEL ACIDO 8-CIANO-1-CICLOPROPIL-7-(1S, 6S-2,8- DIAZABICICLO[4.3.0]-NONAN-8-IL)-6-FLUOR-1, 4-DIHIDRO-4-OXO-3-QUINOLINCARBOXILICO, PROCEDIMIENTO PARA SU OBTENCIoN, MEDICAMENTO Y EMPLEO DE LA MISMA PARA LA FABRICACIoN DE MEDICAMENTOS ANTIBACTERIANOS.
ES2063446T3 (es) Compuesto farmaceutico.
BE835763A (fr) Nouveaux derives de quinoxaline-1,4-dioxyde, procede de preparation de ces derives et medicaments les contenant
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
BE744286A (fr) Nouveaux derives de l'hydrazinopyridazine, leur preparation et medicaments contenant ces derives
AR031216A1 (es) Modificacion cristalina a del acido 8-ciano-1-ciclopropil-7-(1s, 6s-2, 8-diazabiciclo/4. 3. 0/-nonan-8-il)-6-fluor-1, 4-dihidro-4-oxo-3-quinolincarboxilico, procedimiento para su obtencion, medicamento, y empleo de la misma para la fabricacion de medicamentos antibacterianos
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
BE798638A (fr) Derives de la quinazolinone, leur preparation et medicaments contenant ces derives
BE759671A (fr) Derives de la quinazolinone, leur preparation et medicaments contenant ces derives

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 473431

Country of ref document: ES